ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Liver Diseases Therapeutics Drugs Market Research Report 2025
Published Date: August 2025
|
Report Code: QYRE-Auto-24P13681
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Liver Diseases Therapeutics Drugs Market Research Report 2023
BUY CHAPTERS

Global Liver Diseases Therapeutics Drugs Market Research Report 2025

Code: QYRE-Auto-24P13681
Report
August 2025
Pages:89
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
F.Hoffmann-La Roche
Gilead Sciences
Johnson & Johnson
Achillion Pharmaceuticals
AbbVie
Angion Biomedica
LG Life Sciences
Phenex Pharmaceuticals
ProMetic Life Sciences
Raptor Pharmaceuticals
Shenzhen Kangtai Biological Products
Verva Pharmaceuticals
GlaxoSmithKline PLC
Merck
Bayer
Johnson & Johnson

Liver Diseases Therapeutics Drugs Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Liver Diseases Therapeutics Drugs Market

Liver Diseases Therapeutics Drugs Market

The global market for Liver Diseases Therapeutics Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Liver Diseases Therapeutics Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Liver Diseases Therapeutics Drugs.
The Liver Diseases Therapeutics Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Liver Diseases Therapeutics Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Liver Diseases Therapeutics Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Liver Diseases Therapeutics Drugs Market Report

Report Metric Details
Report Name Liver Diseases Therapeutics Drugs Market
CAGR 5%
Segment by Type
Segment by Application
  • Hospitals
  • Clinics
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company F. Hoffmann-La Roche, Gilead Sciences, GlaxoSmithKline, Johnson & Johnson, Merck, Achillion Pharmaceuticals, AbbVie, Angion Biomedica, Bayer, LG Life Sciences, Phenex Pharmaceuticals, ProMetic Life Sciences, Raptor Pharmaceuticals, Shenzhen Kangtai Biological Products, Verva Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Liver Diseases Therapeutics Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Liver Diseases Therapeutics Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Liver Diseases Therapeutics Drugs Market report?

Ans: The main players in the Liver Diseases Therapeutics Drugs Market are F. Hoffmann-La Roche, Gilead Sciences, GlaxoSmithKline, Johnson & Johnson, Merck, Achillion Pharmaceuticals, AbbVie, Angion Biomedica, Bayer, LG Life Sciences, Phenex Pharmaceuticals, ProMetic Life Sciences, Raptor Pharmaceuticals, Shenzhen Kangtai Biological Products, Verva Pharmaceuticals

What are the Application segmentation covered in the Liver Diseases Therapeutics Drugs Market report?

Ans: The Applications covered in the Liver Diseases Therapeutics Drugs Market report are Hospitals, Clinics, Other

What are the Type segmentation covered in the Liver Diseases Therapeutics Drugs Market report?

Ans: The Types covered in the Liver Diseases Therapeutics Drugs Market report are Oral Liver Diseases Therapeutics Drugs, Injection Liver Diseases Therapeutics Drugs

Recommended Reports

Liver Disease Drugs

Other Disease Drugs

Therapeutics & Diagnostics

1 Liver Diseases Therapeutics Drugs Market Overview
1.1 Product Definition
1.2 Liver Diseases Therapeutics Drugs by Type
1.2.1 Global Liver Diseases Therapeutics Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Oral Liver Diseases Therapeutics Drugs
1.2.3 Injection Liver Diseases Therapeutics Drugs
1.3 Liver Diseases Therapeutics Drugs by Application
1.3.1 Global Liver Diseases Therapeutics Drugs Market Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Global Liver Diseases Therapeutics Drugs Market Size Estimates and Forecasts
1.4.1 Global Liver Diseases Therapeutics Drugs Revenue 2020-2031
1.4.2 Global Liver Diseases Therapeutics Drugs Sales 2020-2031
1.4.3 Global Liver Diseases Therapeutics Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Liver Diseases Therapeutics Drugs Market Competition by Manufacturers
2.1 Global Liver Diseases Therapeutics Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Liver Diseases Therapeutics Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Liver Diseases Therapeutics Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Liver Diseases Therapeutics Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Liver Diseases Therapeutics Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Liver Diseases Therapeutics Drugs, Product Type & Application
2.7 Global Key Manufacturers of Liver Diseases Therapeutics Drugs, Date of Enter into This Industry
2.8 Global Liver Diseases Therapeutics Drugs Market Competitive Situation and Trends
2.8.1 Global Liver Diseases Therapeutics Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Liver Diseases Therapeutics Drugs Players Market Share by Revenue
2.8.3 Global Liver Diseases Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Liver Diseases Therapeutics Drugs Market Scenario by Region
3.1 Global Liver Diseases Therapeutics Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Liver Diseases Therapeutics Drugs Sales by Region: 2020-2031
3.2.1 Global Liver Diseases Therapeutics Drugs Sales by Region: 2020-2025
3.2.2 Global Liver Diseases Therapeutics Drugs Sales by Region: 2026-2031
3.3 Global Liver Diseases Therapeutics Drugs Revenue by Region: 2020-2031
3.3.1 Global Liver Diseases Therapeutics Drugs Revenue by Region: 2020-2025
3.3.2 Global Liver Diseases Therapeutics Drugs Revenue by Region: 2026-2031
3.4 North America Liver Diseases Therapeutics Drugs Market Facts & Figures by Country
3.4.1 North America Liver Diseases Therapeutics Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Liver Diseases Therapeutics Drugs Sales by Country (2020-2031)
3.4.3 North America Liver Diseases Therapeutics Drugs Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Liver Diseases Therapeutics Drugs Market Facts & Figures by Country
3.5.1 Europe Liver Diseases Therapeutics Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Liver Diseases Therapeutics Drugs Sales by Country (2020-2031)
3.5.3 Europe Liver Diseases Therapeutics Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Liver Diseases Therapeutics Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Liver Diseases Therapeutics Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Liver Diseases Therapeutics Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Liver Diseases Therapeutics Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Liver Diseases Therapeutics Drugs Market Facts & Figures by Country
3.7.1 Latin America Liver Diseases Therapeutics Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Liver Diseases Therapeutics Drugs Sales by Country (2020-2031)
3.7.3 Latin America Liver Diseases Therapeutics Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Liver Diseases Therapeutics Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Liver Diseases Therapeutics Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Liver Diseases Therapeutics Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Liver Diseases Therapeutics Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Liver Diseases Therapeutics Drugs Sales by Type (2020-2031)
4.1.1 Global Liver Diseases Therapeutics Drugs Sales by Type (2020-2025)
4.1.2 Global Liver Diseases Therapeutics Drugs Sales by Type (2026-2031)
4.1.3 Global Liver Diseases Therapeutics Drugs Sales Market Share by Type (2020-2031)
4.2 Global Liver Diseases Therapeutics Drugs Revenue by Type (2020-2031)
4.2.1 Global Liver Diseases Therapeutics Drugs Revenue by Type (2020-2025)
4.2.2 Global Liver Diseases Therapeutics Drugs Revenue by Type (2026-2031)
4.2.3 Global Liver Diseases Therapeutics Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Liver Diseases Therapeutics Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Liver Diseases Therapeutics Drugs Sales by Application (2020-2031)
5.1.1 Global Liver Diseases Therapeutics Drugs Sales by Application (2020-2025)
5.1.2 Global Liver Diseases Therapeutics Drugs Sales by Application (2026-2031)
5.1.3 Global Liver Diseases Therapeutics Drugs Sales Market Share by Application (2020-2031)
5.2 Global Liver Diseases Therapeutics Drugs Revenue by Application (2020-2031)
5.2.1 Global Liver Diseases Therapeutics Drugs Revenue by Application (2020-2025)
5.2.2 Global Liver Diseases Therapeutics Drugs Revenue by Application (2026-2031)
5.2.3 Global Liver Diseases Therapeutics Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Liver Diseases Therapeutics Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 F. Hoffmann-La Roche
6.1.1 F. Hoffmann-La Roche Company Information
6.1.2 F. Hoffmann-La Roche Description and Business Overview
6.1.3 F. Hoffmann-La Roche Liver Diseases Therapeutics Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 F. Hoffmann-La Roche Liver Diseases Therapeutics Drugs Product Portfolio
6.1.5 F. Hoffmann-La Roche Recent Developments/Updates
6.2 Gilead Sciences
6.2.1 Gilead Sciences Company Information
6.2.2 Gilead Sciences Description and Business Overview
6.2.3 Gilead Sciences Liver Diseases Therapeutics Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Gilead Sciences Liver Diseases Therapeutics Drugs Product Portfolio
6.2.5 Gilead Sciences Recent Developments/Updates
6.3 GlaxoSmithKline
6.3.1 GlaxoSmithKline Company Information
6.3.2 GlaxoSmithKline Description and Business Overview
6.3.3 GlaxoSmithKline Liver Diseases Therapeutics Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 GlaxoSmithKline Liver Diseases Therapeutics Drugs Product Portfolio
6.3.5 GlaxoSmithKline Recent Developments/Updates
6.4 Johnson & Johnson
6.4.1 Johnson & Johnson Company Information
6.4.2 Johnson & Johnson Description and Business Overview
6.4.3 Johnson & Johnson Liver Diseases Therapeutics Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Johnson & Johnson Liver Diseases Therapeutics Drugs Product Portfolio
6.4.5 Johnson & Johnson Recent Developments/Updates
6.5 Merck
6.5.1 Merck Company Information
6.5.2 Merck Description and Business Overview
6.5.3 Merck Liver Diseases Therapeutics Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Merck Liver Diseases Therapeutics Drugs Product Portfolio
6.5.5 Merck Recent Developments/Updates
6.6 Achillion Pharmaceuticals
6.6.1 Achillion Pharmaceuticals Company Information
6.6.2 Achillion Pharmaceuticals Description and Business Overview
6.6.3 Achillion Pharmaceuticals Liver Diseases Therapeutics Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Achillion Pharmaceuticals Liver Diseases Therapeutics Drugs Product Portfolio
6.6.5 Achillion Pharmaceuticals Recent Developments/Updates
6.7 AbbVie
6.7.1 AbbVie Company Information
6.7.2 AbbVie Description and Business Overview
6.7.3 AbbVie Liver Diseases Therapeutics Drugs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 AbbVie Liver Diseases Therapeutics Drugs Product Portfolio
6.7.5 AbbVie Recent Developments/Updates
6.8 Angion Biomedica
6.8.1 Angion Biomedica Company Information
6.8.2 Angion Biomedica Description and Business Overview
6.8.3 Angion Biomedica Liver Diseases Therapeutics Drugs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Angion Biomedica Liver Diseases Therapeutics Drugs Product Portfolio
6.8.5 Angion Biomedica Recent Developments/Updates
6.9 Bayer
6.9.1 Bayer Company Information
6.9.2 Bayer Description and Business Overview
6.9.3 Bayer Liver Diseases Therapeutics Drugs Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Bayer Liver Diseases Therapeutics Drugs Product Portfolio
6.9.5 Bayer Recent Developments/Updates
6.10 LG Life Sciences
6.10.1 LG Life Sciences Company Information
6.10.2 LG Life Sciences Description and Business Overview
6.10.3 LG Life Sciences Liver Diseases Therapeutics Drugs Sales, Revenue and Gross Margin (2020-2025)
6.10.4 LG Life Sciences Liver Diseases Therapeutics Drugs Product Portfolio
6.10.5 LG Life Sciences Recent Developments/Updates
6.11 Phenex Pharmaceuticals
6.11.1 Phenex Pharmaceuticals Company Information
6.11.2 Phenex Pharmaceuticals Description and Business Overview
6.11.3 Phenex Pharmaceuticals Liver Diseases Therapeutics Drugs Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Phenex Pharmaceuticals Liver Diseases Therapeutics Drugs Product Portfolio
6.11.5 Phenex Pharmaceuticals Recent Developments/Updates
6.12 ProMetic Life Sciences
6.12.1 ProMetic Life Sciences Company Information
6.12.2 ProMetic Life Sciences Description and Business Overview
6.12.3 ProMetic Life Sciences Liver Diseases Therapeutics Drugs Sales, Revenue and Gross Margin (2020-2025)
6.12.4 ProMetic Life Sciences Liver Diseases Therapeutics Drugs Product Portfolio
6.12.5 ProMetic Life Sciences Recent Developments/Updates
6.13 Raptor Pharmaceuticals
6.13.1 Raptor Pharmaceuticals Company Information
6.13.2 Raptor Pharmaceuticals Description and Business Overview
6.13.3 Raptor Pharmaceuticals Liver Diseases Therapeutics Drugs Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Raptor Pharmaceuticals Liver Diseases Therapeutics Drugs Product Portfolio
6.13.5 Raptor Pharmaceuticals Recent Developments/Updates
6.14 Shenzhen Kangtai Biological Products
6.14.1 Shenzhen Kangtai Biological Products Company Information
6.14.2 Shenzhen Kangtai Biological Products Description and Business Overview
6.14.3 Shenzhen Kangtai Biological Products Liver Diseases Therapeutics Drugs Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Shenzhen Kangtai Biological Products Liver Diseases Therapeutics Drugs Product Portfolio
6.14.5 Shenzhen Kangtai Biological Products Recent Developments/Updates
6.15 Verva Pharmaceuticals
6.15.1 Verva Pharmaceuticals Company Information
6.15.2 Verva Pharmaceuticals Description and Business Overview
6.15.3 Verva Pharmaceuticals Liver Diseases Therapeutics Drugs Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Verva Pharmaceuticals Liver Diseases Therapeutics Drugs Product Portfolio
6.15.5 Verva Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Liver Diseases Therapeutics Drugs Industry Chain Analysis
7.2 Liver Diseases Therapeutics Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Liver Diseases Therapeutics Drugs Production Mode & Process Analysis
7.4 Liver Diseases Therapeutics Drugs Sales and Marketing
7.4.1 Liver Diseases Therapeutics Drugs Sales Channels
7.4.2 Liver Diseases Therapeutics Drugs Distributors
7.5 Liver Diseases Therapeutics Drugs Customer Analysis
8 Liver Diseases Therapeutics Drugs Market Dynamics
8.1 Liver Diseases Therapeutics Drugs Industry Trends
8.2 Liver Diseases Therapeutics Drugs Market Drivers
8.3 Liver Diseases Therapeutics Drugs Market Challenges
8.4 Liver Diseases Therapeutics Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
F.Hoffmann-La Roche
Gilead Sciences
Johnson & Johnson
Achillion Pharmaceuticals
AbbVie
Angion Biomedica
LG Life Sciences
Phenex Pharmaceuticals
ProMetic Life Sciences
Raptor Pharmaceuticals
Shenzhen Kangtai Biological Products
Verva Pharmaceuticals
GlaxoSmithKline PLC
Merck
Bayer
Johnson & Johnson
List of Tables
 Table 1. Global Liver Diseases Therapeutics Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Liver Diseases Therapeutics Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Liver Diseases Therapeutics Drugs Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Liver Diseases Therapeutics Drugs Sales (K Pcs) of Key Manufacturers (2020-2025)
 Table 5. Global Liver Diseases Therapeutics Drugs Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Liver Diseases Therapeutics Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Liver Diseases Therapeutics Drugs Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Liver Diseases Therapeutics Drugs Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Liver Diseases Therapeutics Drugs, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Liver Diseases Therapeutics Drugs, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Liver Diseases Therapeutics Drugs, Product Type & Application
 Table 12. Global Key Manufacturers of Liver Diseases Therapeutics Drugs, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Liver Diseases Therapeutics Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liver Diseases Therapeutics Drugs as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Liver Diseases Therapeutics Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Liver Diseases Therapeutics Drugs Sales by Region (2020-2025) & (K Pcs)
 Table 18. Global Liver Diseases Therapeutics Drugs Sales Market Share by Region (2020-2025)
 Table 19. Global Liver Diseases Therapeutics Drugs Sales by Region (2026-2031) & (K Pcs)
 Table 20. Global Liver Diseases Therapeutics Drugs Sales Market Share by Region (2026-2031)
 Table 21. Global Liver Diseases Therapeutics Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Liver Diseases Therapeutics Drugs Revenue Market Share by Region (2020-2025)
 Table 23. Global Liver Diseases Therapeutics Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Liver Diseases Therapeutics Drugs Revenue Market Share by Region (2026-2031)
 Table 25. North America Liver Diseases Therapeutics Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Liver Diseases Therapeutics Drugs Sales by Country (2020-2025) & (K Pcs)
 Table 27. North America Liver Diseases Therapeutics Drugs Sales by Country (2026-2031) & (K Pcs)
 Table 28. North America Liver Diseases Therapeutics Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Liver Diseases Therapeutics Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Liver Diseases Therapeutics Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Liver Diseases Therapeutics Drugs Sales by Country (2020-2025) & (K Pcs)
 Table 32. Europe Liver Diseases Therapeutics Drugs Sales by Country (2026-2031) & (K Pcs)
 Table 33. Europe Liver Diseases Therapeutics Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Liver Diseases Therapeutics Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Liver Diseases Therapeutics Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Liver Diseases Therapeutics Drugs Sales by Region (2020-2025) & (K Pcs)
 Table 37. Asia Pacific Liver Diseases Therapeutics Drugs Sales by Region (2026-2031) & (K Pcs)
 Table 38. Asia Pacific Liver Diseases Therapeutics Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Liver Diseases Therapeutics Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Liver Diseases Therapeutics Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Liver Diseases Therapeutics Drugs Sales by Country (2020-2025) & (K Pcs)
 Table 42. Latin America Liver Diseases Therapeutics Drugs Sales by Country (2026-2031) & (K Pcs)
 Table 43. Latin America Liver Diseases Therapeutics Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Liver Diseases Therapeutics Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Liver Diseases Therapeutics Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Liver Diseases Therapeutics Drugs Sales by Country (2020-2025) & (K Pcs)
 Table 47. Middle East and Africa Liver Diseases Therapeutics Drugs Sales by Country (2026-2031) & (K Pcs)
 Table 48. Middle East and Africa Liver Diseases Therapeutics Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Liver Diseases Therapeutics Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Liver Diseases Therapeutics Drugs Sales (K Pcs) by Type (2020-2025)
 Table 51. Global Liver Diseases Therapeutics Drugs Sales (K Pcs) by Type (2026-2031)
 Table 52. Global Liver Diseases Therapeutics Drugs Sales Market Share by Type (2020-2025)
 Table 53. Global Liver Diseases Therapeutics Drugs Sales Market Share by Type (2026-2031)
 Table 54. Global Liver Diseases Therapeutics Drugs Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Liver Diseases Therapeutics Drugs Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Liver Diseases Therapeutics Drugs Revenue Market Share by Type (2020-2025)
 Table 57. Global Liver Diseases Therapeutics Drugs Revenue Market Share by Type (2026-2031)
 Table 58. Global Liver Diseases Therapeutics Drugs Price (USD/Pcs) by Type (2020-2025)
 Table 59. Global Liver Diseases Therapeutics Drugs Price (USD/Pcs) by Type (2026-2031)
 Table 60. Global Liver Diseases Therapeutics Drugs Sales (K Pcs) by Application (2020-2025)
 Table 61. Global Liver Diseases Therapeutics Drugs Sales (K Pcs) by Application (2026-2031)
 Table 62. Global Liver Diseases Therapeutics Drugs Sales Market Share by Application (2020-2025)
 Table 63. Global Liver Diseases Therapeutics Drugs Sales Market Share by Application (2026-2031)
 Table 64. Global Liver Diseases Therapeutics Drugs Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Liver Diseases Therapeutics Drugs Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Liver Diseases Therapeutics Drugs Revenue Market Share by Application (2020-2025)
 Table 67. Global Liver Diseases Therapeutics Drugs Revenue Market Share by Application (2026-2031)
 Table 68. Global Liver Diseases Therapeutics Drugs Price (USD/Pcs) by Application (2020-2025)
 Table 69. Global Liver Diseases Therapeutics Drugs Price (USD/Pcs) by Application (2026-2031)
 Table 70. F. Hoffmann-La Roche Company Information
 Table 71. F. Hoffmann-La Roche Description and Business Overview
 Table 72. F. Hoffmann-La Roche Liver Diseases Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 73. F. Hoffmann-La Roche Liver Diseases Therapeutics Drugs Product
 Table 74. F. Hoffmann-La Roche Recent Developments/Updates
 Table 75. Gilead Sciences Company Information
 Table 76. Gilead Sciences Description and Business Overview
 Table 77. Gilead Sciences Liver Diseases Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 78. Gilead Sciences Liver Diseases Therapeutics Drugs Product
 Table 79. Gilead Sciences Recent Developments/Updates
 Table 80. GlaxoSmithKline Company Information
 Table 81. GlaxoSmithKline Description and Business Overview
 Table 82. GlaxoSmithKline Liver Diseases Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 83. GlaxoSmithKline Liver Diseases Therapeutics Drugs Product
 Table 84. GlaxoSmithKline Recent Developments/Updates
 Table 85. Johnson & Johnson Company Information
 Table 86. Johnson & Johnson Description and Business Overview
 Table 87. Johnson & Johnson Liver Diseases Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 88. Johnson & Johnson Liver Diseases Therapeutics Drugs Product
 Table 89. Johnson & Johnson Recent Developments/Updates
 Table 90. Merck Company Information
 Table 91. Merck Description and Business Overview
 Table 92. Merck Liver Diseases Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 93. Merck Liver Diseases Therapeutics Drugs Product
 Table 94. Merck Recent Developments/Updates
 Table 95. Achillion Pharmaceuticals Company Information
 Table 96. Achillion Pharmaceuticals Description and Business Overview
 Table 97. Achillion Pharmaceuticals Liver Diseases Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 98. Achillion Pharmaceuticals Liver Diseases Therapeutics Drugs Product
 Table 99. Achillion Pharmaceuticals Recent Developments/Updates
 Table 100. AbbVie Company Information
 Table 101. AbbVie Description and Business Overview
 Table 102. AbbVie Liver Diseases Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 103. AbbVie Liver Diseases Therapeutics Drugs Product
 Table 104. AbbVie Recent Developments/Updates
 Table 105. Angion Biomedica Company Information
 Table 106. Angion Biomedica Description and Business Overview
 Table 107. Angion Biomedica Liver Diseases Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 108. Angion Biomedica Liver Diseases Therapeutics Drugs Product
 Table 109. Angion Biomedica Recent Developments/Updates
 Table 110. Bayer Company Information
 Table 111. Bayer Description and Business Overview
 Table 112. Bayer Liver Diseases Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 113. Bayer Liver Diseases Therapeutics Drugs Product
 Table 114. Bayer Recent Developments/Updates
 Table 115. LG Life Sciences Company Information
 Table 116. LG Life Sciences Description and Business Overview
 Table 117. LG Life Sciences Liver Diseases Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 118. LG Life Sciences Liver Diseases Therapeutics Drugs Product
 Table 119. LG Life Sciences Recent Developments/Updates
 Table 120. Phenex Pharmaceuticals Company Information
 Table 121. Phenex Pharmaceuticals Description and Business Overview
 Table 122. Phenex Pharmaceuticals Liver Diseases Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 123. Phenex Pharmaceuticals Liver Diseases Therapeutics Drugs Product
 Table 124. Phenex Pharmaceuticals Recent Developments/Updates
 Table 125. ProMetic Life Sciences Company Information
 Table 126. ProMetic Life Sciences Description and Business Overview
 Table 127. ProMetic Life Sciences Liver Diseases Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 128. ProMetic Life Sciences Liver Diseases Therapeutics Drugs Product
 Table 129. ProMetic Life Sciences Recent Developments/Updates
 Table 130. Raptor Pharmaceuticals Company Information
 Table 131. Raptor Pharmaceuticals Description and Business Overview
 Table 132. Raptor Pharmaceuticals Liver Diseases Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 133. Raptor Pharmaceuticals Liver Diseases Therapeutics Drugs Product
 Table 134. Raptor Pharmaceuticals Recent Developments/Updates
 Table 135. Shenzhen Kangtai Biological Products Company Information
 Table 136. Shenzhen Kangtai Biological Products Description and Business Overview
 Table 137. Shenzhen Kangtai Biological Products Liver Diseases Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 138. Shenzhen Kangtai Biological Products Liver Diseases Therapeutics Drugs Product
 Table 139. Shenzhen Kangtai Biological Products Recent Developments/Updates
 Table 140. Verva Pharmaceuticals Company Information
 Table 141. Verva Pharmaceuticals Description and Business Overview
 Table 142. Verva Pharmaceuticals Liver Diseases Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 143. Verva Pharmaceuticals Liver Diseases Therapeutics Drugs Product
 Table 144. Verva Pharmaceuticals Recent Developments/Updates
 Table 145. Key Raw Materials Lists
 Table 146. Raw Materials Key Suppliers Lists
 Table 147. Liver Diseases Therapeutics Drugs Distributors List
 Table 148. Liver Diseases Therapeutics Drugs Customers List
 Table 149. Liver Diseases Therapeutics Drugs Market Trends
 Table 150. Liver Diseases Therapeutics Drugs Market Drivers
 Table 151. Liver Diseases Therapeutics Drugs Market Challenges
 Table 152. Liver Diseases Therapeutics Drugs Market Restraints
 Table 153. Research Programs/Design for This Report
 Table 154. Key Data Information from Secondary Sources
 Table 155. Key Data Information from Primary Sources
 Table 156. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Liver Diseases Therapeutics Drugs
 Figure 2. Global Liver Diseases Therapeutics Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Liver Diseases Therapeutics Drugs Market Share by Type: 2024 & 2031
 Figure 4. Oral Liver Diseases Therapeutics Drugs Product Picture
 Figure 5. Injection Liver Diseases Therapeutics Drugs Product Picture
 Figure 6. Global Liver Diseases Therapeutics Drugs Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Liver Diseases Therapeutics Drugs Market Share by Application: 2024 & 2031
 Figure 8. Hospitals
 Figure 9. Clinics
 Figure 10. Other
 Figure 11. Global Liver Diseases Therapeutics Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Liver Diseases Therapeutics Drugs Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Liver Diseases Therapeutics Drugs Sales (2020-2031) & (K Pcs)
 Figure 14. Global Liver Diseases Therapeutics Drugs Average Price (USD/Pcs) & (2020-2031)
 Figure 15. Liver Diseases Therapeutics Drugs Report Years Considered
 Figure 16. Liver Diseases Therapeutics Drugs Sales Share by Manufacturers in 2024
 Figure 17. Global Liver Diseases Therapeutics Drugs Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Liver Diseases Therapeutics Drugs Players: Market Share by Revenue in Liver Diseases Therapeutics Drugs in 2024
 Figure 19. Liver Diseases Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Liver Diseases Therapeutics Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Liver Diseases Therapeutics Drugs Sales Market Share by Country (2020-2031)
 Figure 22. North America Liver Diseases Therapeutics Drugs Revenue Market Share by Country (2020-2031)
 Figure 23. U.S. Liver Diseases Therapeutics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Liver Diseases Therapeutics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Liver Diseases Therapeutics Drugs Sales Market Share by Country (2020-2031)
 Figure 26. Europe Liver Diseases Therapeutics Drugs Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Liver Diseases Therapeutics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Liver Diseases Therapeutics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Liver Diseases Therapeutics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Liver Diseases Therapeutics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Liver Diseases Therapeutics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Liver Diseases Therapeutics Drugs Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Liver Diseases Therapeutics Drugs Revenue Market Share by Region (2020-2031)
 Figure 34. China Liver Diseases Therapeutics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Liver Diseases Therapeutics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Liver Diseases Therapeutics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Liver Diseases Therapeutics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Liver Diseases Therapeutics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Liver Diseases Therapeutics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia Liver Diseases Therapeutics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand Liver Diseases Therapeutics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia Liver Diseases Therapeutics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Liver Diseases Therapeutics Drugs Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Liver Diseases Therapeutics Drugs Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Liver Diseases Therapeutics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Liver Diseases Therapeutics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Liver Diseases Therapeutics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Liver Diseases Therapeutics Drugs Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Liver Diseases Therapeutics Drugs Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Liver Diseases Therapeutics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Liver Diseases Therapeutics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE Liver Diseases Therapeutics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Liver Diseases Therapeutics Drugs by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Liver Diseases Therapeutics Drugs by Type (2020-2031)
 Figure 55. Global Liver Diseases Therapeutics Drugs Price (USD/Pcs) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Liver Diseases Therapeutics Drugs by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Liver Diseases Therapeutics Drugs by Application (2020-2031)
 Figure 58. Global Liver Diseases Therapeutics Drugs Price (USD/Pcs) by Application (2020-2031)
 Figure 59. Liver Diseases Therapeutics Drugs Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

Chronic Liver Diseases Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Liver Cirrhosis Therapeutics Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Liver Failure Therapeutics Market Research Report 2025
Liver Cancer Diagnostic Tests Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Liver Cancer Treatment Drug Market Research Report 2025
Global Alcoholic Hepatiti Drug Market Research Report 2024
Liver Cancer Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Adult Chronic Hepatitis B Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Hepatitis B Virus Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Hepatitis Viruses Diagnostic Tests Market Research Report 2024
Hepatocellular Carcinoma Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Hepatic Encephalopathy Drug Market Research Report 2024
Lung Disease Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Hepatitis C Virus Drugs Market Research Report 2025
Antiviral Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Lung Disease Therapeutic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Lung Disease Therapeutic Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Primary Biliary Cirrhosis Drug Market Research Report 2024
Global Anti HBV Drugs Market Research Report 2025
Ophthalmic Disease Therapeutic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions